Investigation and inquest
On 24th September 2018 I commenced an investigation into the death of Andrew Peter McCall. The investigation concluded at the end of the inquest on 27th June 2019. The conclusion of the inquest was that the death was drug related. The deceased was found face down at ████████
████████ on 18th September 2018 after concern was raised for his welfare. The accommodation was “supported living accommodation” for vulnerable individuals. The deceased had a history of drug misuse and was on a methadone programme. He was also prescribed pregabalin by his GP. The cause of death given after a post mortem examination was :-
1a Gastric aspiration.
1b Pregabalin and methadone use.
1c –
II –
Circumstances of the death
The deceased was found face down unresponsive in his supported living accommodation on 18th September 2018 after concern was raised for his welfare. He had a history of difficulties with illicit drugs and was on a Methadone prescription which was managed by the “One Recovery Clinic”. He was also prescribed a number of medications by his GP. A Post Mortem examination together with toxicology provided that he had died from the effect of gastric aspiration due to Pregabalin and Methadone use.
Coroner’s concerns
The evidence revealed a clear pattern of “medication seeking behaviour” with his GP to obtain additional amounts of Pregabalin. The evidence also showed that his GP was not aware that he was on a current Methadone script. The “One Recovery” clinic operated a system which was dependent upon the service user declaring which GP practice they were registered with. This was not checked or verified independently and therefore concern must exist that the GP may be unaware that a patient is on an opiate replacement regime, prescribed by another organisation, and may therefore prescribe medications which may not be suitable and which may potentially be harmful. It is suggested that, where patients are prescribed medication as part of “opiate replacement therapy”, GPs have the means to check the details and the organisation providing such a service. This puts in place a more robust system to ensure that the current GP is fully aware of the treatment programme.